Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elisabeth Carilla-Durand
Observed names:
E Carilla-Durand,
E. Cariila-Durand,
E. Carilla-Durand,
Elizabeth Carilla-Durand
Institution:
Pierre Fabre (France)
Observed institution:
Pierre Fabre (France)
OpenAlex ID:
A5110055161
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia
2002
·
F.C Colpaert
, J.P Tarayre
, et al.
·
Neuropharmacology
·
151
F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity
2010
·
Marie-Bernadette Assié
, Laurent Bardin
, et al.
·
The International Journal of Neuropsychopharmacology
·
119
PDF
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release
2006
·
Cristina Cosi
, Elisabeth Carilla-Durand
, et al.
·
European Journal of Pharmacology
·
91
F 11440, a Potent, Selective, High Efficacy 5-HT1AReceptor Agonist with Marked Anxiolytic and Antidepressant Potential
1998
·
W. Koek
, J.-F. Patoiseau
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
68
The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: Comparison with aripiprazole, ziprasidone, bifeprunox and F15063
2008
·
Marie-Bernadette Assié
, Elisabeth Carilla-Durand
, et al.
·
European Journal of Pharmacology
·
64
F 11356, a Novel 5-Hydroxytryptamine (5-HT) Derivative with Potent, Selective, and Unique High Intrinsic Activity at 5-HT1B/1D Receptors in Models Relevant to Migraine
1999
·
Gareth W. John
, Petrus J. Pauwels
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
48
Pharmacological profile of F 12511, (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor
2001
·
Didier Junquero
, Philippe Oms
, et al.
·
Biochemical Pharmacology
·
33
Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture11Abbreviations: ACAT, acyl-coenzyme A: cholesterol O-acyltransferase; F 12511, (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthio-phenylacetanilide; DMEM, Dulbecco’s modified Eagle medium; FBS, fetal bovine serum; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SR-BI, scavenger receptor class B, type I; P450scc, cytochrome P450 cholesterol side-chain cleavage; P450c17, cytochrome P450 17 α-hydroxylase; P450c21, cytochrome P450 21-hydroxylase; PMA, phorbol 12-myristate 13-acetate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; cAMP, adenosine 3′5′-cyclic monophosphate; ITS, insulin-transferrin-linoleic acid; and MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
2001
·
Didier Junquero
, Antoine Pilon
, et al.
·
Biochemical Pharmacology
·
20
NLX-112, a highly selective 5-HT1A receptor agonist: Effects on body temperature and plasma corticosterone levels in rats
2017
·
A. Newman-Tancredi
, R. Depoortère
, et al.
·
Pharmacology Biochemistry and Behavior
·
8
P.1.c.018 F15599, a highly selective serotonin 5-HT1A receptor agonist: in vivo profile in neurochemical and behavioural models of serotonergic activity
2006
·
M.B. Assié
, L. Bardin
, et al.
·
European Neuropsychopharmacology
·
8
P.3.d.004 F15063, a novel antipsychotic with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: I. Receptor affinity and efficacy in vitro and activity in neurochemical and neuroendocrine tests in rodents
2006
·
A. Newman-Tancredi
, M.B. Assié
, et al.
·
European Neuropsychopharmacology
·
4
Effects of F 12511, a potent ACAT inhibitor, on human adrenocortical cells in culture
1999
·
A. Delhon
, D. Junquero
, et al.
·
Atherosclerosis
The Use of Irreversible Antagonists for the Characterization of 5-ht1a Agonist Effects
1998
·
W. Koek
, C. Cosi
, et al.
·
Behavioural Pharmacology
The Use of Irreversible Antagonists for the Characterization of 5-ht1a Agonist Effects
1998
·
W. Koek
, C. Cosi
, et al.
·
Behavioural Pharmacology
The Use of Irreversible Antagonists for the Characterization of 5-ht1a Agonist Effects
1998
·
W. Koek
, C. Cosi
, et al.
·
Behavioural Pharmacology
Show more works
View as search
Works count:
15
Citation count:
614
H-index:
8
I10-index:
8
Year
Topic
Type